Skip to content

Clinical trials

Completed Phase 2 Giant Cell Arteritis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Giant Cell Arteritis Phase: Phase 2 Status: Completed Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20111
20131
20171
20181
20193

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre Hospitalier Universitaire Dijon1
Insel Gruppe AG, University Hospital Bern1
Kiniksa Pharmaceuticals, Ltd.1
Matthew J Koster1
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)1
Novartis Pharmaceuticals1
The Cleveland Clinic1
University of Alberta1
University of Pennsylvania1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Giant Cell Arteritis9
Takayasu Arteritis2
Arteritis1
Churg-Strauss Syndrome1
Granulomatosis with Polyangiitis1
Microscopic Polyangiitis1
Polyarteritis Nodosa1
Rare Diseases1
Respiratory Tract Diseases1
Vasculitis1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.